Education
About Us
Working with TipRanks
Follow Us
Pharmagreen Biotech Inc. (PHBI)
OTHER OTC:PHBI
PHBI Stock Chart & Stats
<$0.01
$0.00(0.00%)
At close: 4:00 PM EST
<$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range<$0.01 - $0.03
Previous CloseN/A
Volume191.24K
Average Volume (3M)N/A
Market Cap
$1.33M
Enterprise Value$1.59M
Total Cash (Recent Filing)$568.00
Total Debt (Recent Filing)$354.33K
Price to Earnings (P/E)―
Beta0.52
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding663,645,750
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio-0.11
Price to Book (P/B)-0.90
Price to Sales (P/S)812.27
P/FCF Ratio-98.62
Enterprise Value/Market Cap1.20
Enterprise Value/Revenue882.83
Enterprise Value/Gross Profit-2.44K
Enterprise Value/Ebitda-7.97
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Proprietary TechnologyThe use of proprietary technology like 'Chibafreen' provides a competitive edge by ensuring high-quality, disease-free plantlets, crucial for consistent crop yields in the cannabis industry.
Market DemandThe growing legal cannabis market and demand for high-quality plant materials present opportunities for revenue growth, supporting long-term business prospects.
B2B ModelA B2B model focused on commercial growers ensures a stable customer base and aligns with industry needs, enhancing revenue stability and growth potential.
Bears Say
Negative EquityNegative equity reflects financial instability, limiting the company's ability to secure financing and invest in growth, posing a risk to long-term operations.
Cash Flow IssuesPersistent negative cash flow indicates operational inefficiencies and financial strain, threatening the company's ability to sustain operations without external funding.
Profitability ChallengesOngoing profitability issues, marked by negative income and margins, hinder the company's ability to reinvest in growth and improve financial health.
PHBI FAQ
What was Pharmagreen Biotech Inc.’s price range in the past 12 months?
Pharmagreen Biotech Inc. lowest stock price was <$0.01 and its highest was $0.03 in the past 12 months.
What is Pharmagreen Biotech Inc.’s market cap?
Pharmagreen Biotech Inc.’s market cap is $1.33M.
When is Pharmagreen Biotech Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Pharmagreen Biotech Inc.’s earnings last quarter?
Currently, no data Available
Is Pharmagreen Biotech Inc. overvalued?
According to Wall Street analysts Pharmagreen Biotech Inc.’s price is currently Overvalued.
Does Pharmagreen Biotech Inc. pay dividends?
Pharmagreen Biotech Inc. does not currently pay dividends.
What is Pharmagreen Biotech Inc.’s EPS estimate?
Pharmagreen Biotech Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Pharmagreen Biotech Inc. have?
Pharmagreen Biotech Inc. has 663,645,750 shares outstanding.
What happened to Pharmagreen Biotech Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Pharmagreen Biotech Inc.?
Currently, no hedge funds are holding shares in PHBI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Pharmagreen Biotech Inc.
Pharmagreen Biotech Inc., a biotech sciences solutions company, focuses on the production of starter plantlets for CBD hemp and medical cannabis industries. The company was incorporated in 2007 and is headquartered in Coquitlam, Canada.